Ascend Wellness Holdings, a vertically integrated cannabis operator, announced the launch of its new edibles-only brand, ‘Effin’. The brand focuses on delivering specific effects through expertly formulated combinations of THC and minor cannabinoids. Effin’ initially debuted in Massachusetts and Illinois and is set to launch in New Jersey soon, offering unique SKUs targeting chill, sleep, focus, and energy.
Recent research has unveiled the potential anticancer properties of cannabinoids like THC, CBD, and CBG, sparking optimism for their role in inhibiting tumor growth and improving palliative care. However, despite promising findings, challenges remain in understanding their mechanisms and translating these discoveries into effective clinical applications. The article explores the potential benefits, research gaps, and regulatory hurdles hindering wider adoption of cannabinoids in cancer treatment.
